Roche to pay $4.3bn for Spark in gene therapy move
Roche has announced plans to buy Spark Therapeutics for $4.3 billion.
Read More
Tag: Spark Therapeutics
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
